Renaissance Technologies - PLX PHARMA INC ownership

PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 16 filers reported holding PLX PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PLX PHARMA INC
ValueSharesWeighting
Q1 2023$5
-44.4%
37,000
-32.1%
0.00%
Q4 2022$9
-100.0%
54,500
-73.9%
0.00%
-100.0%
Q2 2021$2,884,000
+14.7%
208,983
-25.0%
0.00%
+33.3%
Q1 2021$2,515,000
+227.5%
278,551
+100.3%
0.00%
+200.0%
Q4 2020$768,000
+206.0%
139,083
+79.0%
0.00%
Q3 2020$251,000
+4.6%
77,683
+5.0%
0.00%
Q2 2020$240,000
+43.7%
73,983
-0.6%
0.00%
Q1 2020$167,000
-45.4%
74,400
+6.1%
0.00%
Q4 2019$306,000
-12.6%
70,111
+2.0%
0.00%
Q3 2019$350,000
-24.9%
68,711
+6.2%
0.00%
Q2 2019$466,000
+51.3%
64,711
+10.4%
0.00%
Q1 2019$308,000
+359.7%
58,612
+34.1%
0.00%
Q4 2018$67,000
-60.4%
43,712
+4.8%
0.00%
Q3 2018$169,000
-39.9%
41,712
-46.2%
0.00%
Q2 2018$281,000
+119.5%
77,524
+102.9%
0.00%
Q1 2018$128,000
-42.9%
38,212
+17.5%
0.00%
Q4 2017$224,000
+54.5%
32,512
+44.4%
0.00%
Q3 2017$145,00022,5120.00%
Other shareholders
PLX PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
MSD Partners, L.P. 1,875,000$7,575,0000.41%
Ground Swell Capital, LLC 31,150$126,0000.32%
Park West Asset Management LLC 1,473,218$5,952,0000.21%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 62,673$253,0000.13%
O'Brien Greene & Co. Inc 60,340$244,0000.08%
Eidelman Virant Capital 27,000$109,0000.06%
MBL Wealth, LLC 52,000$210,0000.05%
Shay Capital LLC 88,620$358,0000.05%
EXANE DERIVATIVES 13,407$54,161,0000.02%
GW&K Investment Management, LLC 428,171$1,730,0000.02%
View complete list of PLX PHARMA INC shareholders